Propanc Biopharma announces publication of pilot study
The company announced publication of a pilot study on its PRP pancreatic proenzyme formulation in pancreatic and ovarian cancer.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
The company announced publication of a pilot study on its PRP pancreatic proenzyme formulation in pancreatic and ovarian cancer.